Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Can-Fite Biopharma Ltd (CANF)

1.8   -0.15 (-7.69%) 03-05 07:55
Open: 1.95 Pre. Close: 1.95
High: 1.95 Low: 1.75
Volume: 581,127 Market Cap: 31M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.963 - 1.982 1.982 - 1.993
Low: 1.713 - 1.736 1.736 - 1.75
Close: 1.773 - 1.811 1.811 - 1.834

Technical analysis

as of: 2021-03-04 5:05:50 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.93     One year: 3.48
Support: Support1: 1.75    Support2: 1.46
Resistance: Resistance1: 2.51    Resistance2: 2.98
Pivot: 2.29
Moving Average: MA(5): 1.96     MA(20): 2.28
MA(100): 1.95     MA(250): 1.91
MACD: MACD(12,26): -0.04     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 4.54     %D(3): 5.71
RSI: RSI(14): 36.23
52-week: High: 2.98  Low: 1.15  Change(%): 7.8
Average Vol(K): 3-Month: 113037  10-Days: 219201

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CANF has closed above bottom band by 5.7%. Bollinger Bands are 186.2% wider than normal. The large width of the bands suggest high volatility as compared to CANF's normal range. The bands have been in this wide range for 17 bars. This is a sign that the current trend might continue.

Headline News

Fri, 05 Mar 2021
Form 6-K Can-Fite BioPharma Ltd. For: Mar 05 -

Mon, 22 Feb 2021
New Positive Data from Can-Fite's Liver Cancer Phase II Clinical Study with Namodenoson - BioSpace

Wed, 10 Feb 2021
Is Can Fite Biopharma ADR Representing 30 Ord Shs (CANF) a Stock to Watch This Week? - InvestorsObserver

Wed, 03 Feb 2021
Is Can Fite Biopharma ADR Representing 30 Ord Shs (CANF) Stock About to Get Hot Wednesday? - InvestorsObserver

Sat, 16 Jan 2021
CANF Stock Price, Can-Fite Biopharma Ltd Sponsored ADR (Israel) Stock Quotes and News - Benzinga

Mon, 14 Dec 2020
Can-Fite Reports on Progress With Its Namodenoson NASH Program - Business Wire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Neutral Discounted cash flow: Neutral
Return on Assets: Neutral Price to Earnings: Neutral
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15
Shares Float (M) 13
% Held by Insiders 1.99
% Held by Institutions 9.22
Shares Short (K) 332
Shares Short P. Month (K) 437

Stock Financials

EPS -2.220
EPS Est This Year -0.270
EPS Est Next Year -0.610
Book Value (p.s.) 0.660
Profit Margin
Operating Margin -888.03
Return on Assets (ttm) -73.2
Return on Equity (ttm) -146.9
Qtrly Rev. Growth -47.6
Gross Profit (p.s.) 0.132
Sales Per Share 0.114
EBITDA (p.s.) -1.005
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -10

Stock Valuations

PE Ratio -0.81
PEG Ratio
Price to Book value 2.73
Price to Sales 15.85
Price to Cash Flow -2.02

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.